NGM707

Other Medications

EU Not submitted to EMA ES Not available 1 Clinical Trials

Description

NGM707 is an investigational medicine currently being studied in clinical trials for advanced or metastatic solid tumors, including colorectal cancer. It is being tested both by itself (as monotherapy) and in combination with another immunotherapy drug called pembrolizumab. The goal of these early-phase trials is to determine the safety and tolerability of NGM707, and to see if it has any anti-cancer activity. NGM707 is not yet approved for treating colorectal cancer or any other condition. These trials are helping researchers understand how NGM707 works and if it could be a potential treatment option in the future.

Mechanism of Action

NGM707 is being investigated as a potential treatment for cancer. The specific way it works (its mechanism of action) is still being studied in clinical trials. Researchers are evaluating how it interacts with the body and cancer cells to determine its potential effects.

Side Effects

Because NGM707 is still in early-phase clinical trials (Phase 1) The full range of potential side effects is still being evaluated. Information about side effects from these trials is limited but is being carefully monitored by the researchers to ensure patient safety. Common side effects seen in early cancer drug trials can vary widely depending on the drug and the patients involved.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT04913337 Phase 1
Active, not recruiting
Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
United States, South Korea, Taiwan

Quick Info

CategoryOther Medications
EU EMA StatusNot submitted to EMA
ES Spain AccessNot available
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
771 trials
Leucovorin
Other Medications
631 trials
Trifluridine
Other Medications
45 trials
Paclitaxel
Other Medications
43 trials
Cyclophosphamid
Other Medications
40 trials
Cyclophosphamide
Other Medications
39 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.